Healthcare provider profile · identity verified

Bruce G Thorkildsen, M.D.

Internal Medicine · ALLENTOWN, PA · NPI 1215970769

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	513	131
Levothyroxine Sodium	Levothyroxine Sodium	362	72
Amlodipine Besylate	Amlodipine Besylate	355	79
Losartan Potassium	Losartan Potassium	274	60
Lisinopril	Lisinopril	228	63
Metoprolol Succinate	Metoprolol Succinate	219	40
Pantoprazole Sodium	Pantoprazole Sodium	199	53
Famotidine	Famotidine	185	38
Furosemide	Furosemide	180	46
Valsartan	Valsartan	171	46
Rosuvastatin Calcium	Rosuvastatin Calcium	169	38
Omeprazole	Omeprazole	161	49
Eliquis	Apixaban	159	26
Simvastatin	Simvastatin	138	31
Gabapentin	Gabapentin	129	32
Metformin Hcl	Metformin Hcl	123	38
Metoprolol Tartrate	Metoprolol Tartrate	117	39
Albuterol Sulfate Hfa	Albuterol Sulfate	104	27
Potassium Chloride	Potassium Chloride	103	26
Clopidogrel	Clopidogrel Bisulfate	96	17
Escitalopram Oxalate	Escitalopram Oxalate	95	19
Tramadol Hcl	Tramadol Hcl	93	18
Montelukast Sodium	Montelukast Sodium	91	23
Tamsulosin Hcl	Tamsulosin Hcl	87	25
Lorazepam	Lorazepam	86	26
Torsemide	Torsemide	86	20
Allopurinol	Allopurinol	81	22
Metformin Hcl Er	Metformin Hcl	79	24
Hydrochlorothiazide	Hydrochlorothiazide	76	19
Citalopram Hbr	Citalopram Hydrobromide	73	suppressed
Ezetimibe	Ezetimibe	73	19
Pravastatin Sodium	Pravastatin Sodium	73	14
Atenolol	Atenolol	72	14
Zolpidem Tartrate	Zolpidem Tartrate	72	13
Doxazosin Mesylate	Doxazosin Mesylate	71	12
Tizanidine Hcl	Tizanidine Hcl	70	19
Fluticasone Propionate	Fluticasone Propionate	66	19
Sertraline Hcl	Sertraline Hcl	66	18
Tradjenta	Linagliptin	66	suppressed
Xarelto	Rivaroxaban	66	suppressed
Alprazolam	Alprazolam	63	26
Finasteride	Finasteride	62	15
Carvedilol	Carvedilol	60	16
Pioglitazone Hcl	Pioglitazone Hcl	58	14
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	55	15
Donepezil Hcl	Donepezil Hcl	53	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	53	suppressed
Prednisone	Prednisone	52	18
Diclofenac Sodium	Diclofenac Sodium	51	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	46	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	45	suppressed
Azelastine Hcl	Azelastine Hcl	44	16
Fluoxetine Hcl	Fluoxetine Hcl	44	suppressed
Chlorthalidone	Chlorthalidone	42	suppressed
Glimepiride	Glimepiride	42	12
Benazepril Hcl	Benazepril Hcl	41	suppressed
Clonidine Hcl	Clonidine Hcl	39	suppressed
Irbesartan	Irbesartan	39	suppressed
Labetalol Hcl	Labetalol Hcl	39	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	37	suppressed
Pregabalin	Pregabalin	37	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	36	suppressed
Methocarbamol	Methocarbamol	36	suppressed
Mirtazapine	Mirtazapine	36	14
Paroxetine Hcl	Paroxetine Hcl	36	suppressed
Novolog Flexpen	Insulin Aspart	35	suppressed
Duloxetine Hcl	Duloxetine Hcl	32	suppressed
Latanoprost	Latanoprost	32	suppressed
Metolazone	Metolazone	32	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	32	suppressed
Clonazepam	Clonazepam	31	11
Meloxicam	Meloxicam	31	12
Ozempic	Semaglutide	31	suppressed
Spironolactone	Spironolactone	31	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	30	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Januvia	Sitagliptin Phosphate	30	suppressed
Ondansetron Hcl	Ondansetron Hcl	30	suppressed
Primidone	Primidone	30	suppressed
Alendronate Sodium	Alendronate Sodium	29	suppressed
Nabumetone	Nabumetone	28	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	27	suppressed
Bupropion Hcl Sr	Bupropion Hcl	27	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	27	suppressed
Cholestyramine	Cholestyramine (With Sugar)	26	suppressed
Nifedipine Er	Nifedipine	26	suppressed
Synthroid	Levothyroxine Sodium	26	suppressed
Jardiance	Empagliflozin	25	suppressed
Oxycodone Hcl	Oxycodone Hcl	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Lovastatin	Lovastatin	23	suppressed
Solifenacin Succinate	Solifenacin Succinate	23	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	23	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	22	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	22	suppressed
Nystatin	Nystatin	22	12
Amoxicillin	Amoxicillin	21	15
Candesartan Cilexetil	Candesartan Cilexetil	21	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	21	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	21	suppressed
Ramipril	Ramipril	21	suppressed
Trospium Chloride	Trospium Chloride	20	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Cefadroxil	Cefadroxil	19	17
Ketoconazole	Ketoconazole	19	14
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Indapamide	Indapamide	18	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	18	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	18	suppressed
Glipizide Er	Glipizide	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Bumetanide	Bumetanide	16	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	16	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Azithromycin	Azithromycin	15	suppressed
Bupropion Hcl	Bupropion Hcl	15	suppressed
Colchicine	Colchicine	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Gemfibrozil	Gemfibrozil	15	suppressed
Imipramine Hcl	Imipramine Hcl	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	14
Cephalexin	Cephalexin	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	suppressed
Ibandronate Sodium	Ibandronate Sodium	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Mometasone Furoate	Mometasone Furoate	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Methylprednisolone	Methylprednisolone	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Savella	Milnacipran Hcl	13	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Trazodone Hcl	Trazodone Hcl	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Diazepam	Diazepam	11	suppressed
Dutasteride	Dutasteride	11	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Temazepam	Temazepam	11	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error